ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza A Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-11Q14017
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza A Vaccine Market Research Report 2023
BUY CHAPTERS

Global Influenza A Vaccine Market Research Report 2025

Code: QYRE-Auto-11Q14017
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MedImmune
Abbott
Merck
SINOVAC BIOTECH
Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Mitsubishi Tanabe Pharma
GSK
Sanofi
Novartis
Hualan Biological Engineering

Influenza A Vaccine Market Size

The global market for Influenza A Vaccine was valued at US$ 8124 million in the year 2024 and is projected to reach a revised size of US$ 12390 million by 2031, growing at a CAGR of 6.3% during the forecast period.

Influenza A Vaccine Market

Influenza A Vaccine Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza A Vaccine.
The Influenza A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Influenza A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Influenza A Vaccine Market Report

Report Metric Details
Report Name Influenza A Vaccine Market
Accounted market size in year US$ 8124 million
Forecasted market size in 2031 US$ 12390 million
CAGR 6.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • 3-18 Years Old
  • Above 18 Years Old
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech, Hualan Biological Engineering, Changsheng Bio-Technology, Beijing Tiantan Bio-Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Influenza A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Influenza A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Influenza A Vaccine Market growing?

Ans: The Influenza A Vaccine Market witnessing a CAGR of 6.3% during the forecast period 2025-2031.

What is the Influenza A Vaccine Market size in 2031?

Ans: The Influenza A Vaccine Market size in 2031 will be US$ 12390 million.

Who are the main players in the Influenza A Vaccine Market report?

Ans: The main players in the Influenza A Vaccine Market are Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech, Hualan Biological Engineering, Changsheng Bio-Technology, Beijing Tiantan Bio-Products

What are the Application segmentation covered in the Influenza A Vaccine Market report?

Ans: The Applications covered in the Influenza A Vaccine Market report are 3-18 Years Old, Above 18 Years Old

What are the Type segmentation covered in the Influenza A Vaccine Market report?

Ans: The Types covered in the Influenza A Vaccine Market report are Intramuscular Vaccine, Nasal Spray Vaccine

Recommended Reports

Vaccine Technologies

Vaccine Components

Vaccine Logistics

1 Influenza A Vaccine Market Overview
1.1 Product Definition
1.2 Influenza A Vaccine by Type
1.2.1 Global Influenza A Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intramuscular Vaccine
1.2.3 Nasal Spray Vaccine
1.3 Influenza A Vaccine by Application
1.3.1 Global Influenza A Vaccine Market Value by Application (2024 VS 2031)
1.3.2 3-18 Years Old
1.3.3 Above 18 Years Old
1.4 Global Influenza A Vaccine Market Size Estimates and Forecasts
1.4.1 Global Influenza A Vaccine Revenue 2020-2031
1.4.2 Global Influenza A Vaccine Sales 2020-2031
1.4.3 Global Influenza A Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Influenza A Vaccine Market Competition by Manufacturers
2.1 Global Influenza A Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Influenza A Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Influenza A Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Influenza A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza A Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza A Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Influenza A Vaccine, Date of Enter into This Industry
2.8 Global Influenza A Vaccine Market Competitive Situation and Trends
2.8.1 Global Influenza A Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Influenza A Vaccine Players Market Share by Revenue
2.8.3 Global Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Influenza A Vaccine Market Scenario by Region
3.1 Global Influenza A Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Influenza A Vaccine Sales by Region: 2020-2031
3.2.1 Global Influenza A Vaccine Sales by Region: 2020-2025
3.2.2 Global Influenza A Vaccine Sales by Region: 2026-2031
3.3 Global Influenza A Vaccine Revenue by Region: 2020-2031
3.3.1 Global Influenza A Vaccine Revenue by Region: 2020-2025
3.3.2 Global Influenza A Vaccine Revenue by Region: 2026-2031
3.4 North America Influenza A Vaccine Market Facts & Figures by Country
3.4.1 North America Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Influenza A Vaccine Sales by Country (2020-2031)
3.4.3 North America Influenza A Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Influenza A Vaccine Market Facts & Figures by Country
3.5.1 Europe Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Influenza A Vaccine Sales by Country (2020-2031)
3.5.3 Europe Influenza A Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza A Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Influenza A Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Influenza A Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Influenza A Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Influenza A Vaccine Market Facts & Figures by Country
3.7.1 Latin America Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Influenza A Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Influenza A Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza A Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza A Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Influenza A Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Influenza A Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza A Vaccine Sales by Type (2020-2031)
4.1.1 Global Influenza A Vaccine Sales by Type (2020-2025)
4.1.2 Global Influenza A Vaccine Sales by Type (2026-2031)
4.1.3 Global Influenza A Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Influenza A Vaccine Revenue by Type (2020-2031)
4.2.1 Global Influenza A Vaccine Revenue by Type (2020-2025)
4.2.2 Global Influenza A Vaccine Revenue by Type (2026-2031)
4.2.3 Global Influenza A Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Influenza A Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Influenza A Vaccine Sales by Application (2020-2031)
5.1.1 Global Influenza A Vaccine Sales by Application (2020-2025)
5.1.2 Global Influenza A Vaccine Sales by Application (2026-2031)
5.1.3 Global Influenza A Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Influenza A Vaccine Revenue by Application (2020-2031)
5.2.1 Global Influenza A Vaccine Revenue by Application (2020-2025)
5.2.2 Global Influenza A Vaccine Revenue by Application (2026-2031)
5.2.3 Global Influenza A Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Influenza A Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Influenza A Vaccine Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Influenza A Vaccine Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Influenza A Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Medimmune
6.4.1 Medimmune Company Information
6.4.2 Medimmune Description and Business Overview
6.4.3 Medimmune Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medimmune Influenza A Vaccine Product Portfolio
6.4.5 Medimmune Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Influenza A Vaccine Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Company Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Influenza A Vaccine Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Sinovac Biotech
6.8.1 Sinovac Biotech Company Information
6.8.2 Sinovac Biotech Description and Business Overview
6.8.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sinovac Biotech Influenza A Vaccine Product Portfolio
6.8.5 Sinovac Biotech Recent Developments/Updates
6.9 Hualan Biological Engineering
6.9.1 Hualan Biological Engineering Company Information
6.9.2 Hualan Biological Engineering Description and Business Overview
6.9.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hualan Biological Engineering Influenza A Vaccine Product Portfolio
6.9.5 Hualan Biological Engineering Recent Developments/Updates
6.10 Changsheng Bio-Technology
6.10.1 Changsheng Bio-Technology Company Information
6.10.2 Changsheng Bio-Technology Description and Business Overview
6.10.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Changsheng Bio-Technology Influenza A Vaccine Product Portfolio
6.10.5 Changsheng Bio-Technology Recent Developments/Updates
6.11 Beijing Tiantan Bio-Products
6.11.1 Beijing Tiantan Bio-Products Company Information
6.11.2 Beijing Tiantan Bio-Products Description and Business Overview
6.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Product Portfolio
6.11.5 Beijing Tiantan Bio-Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza A Vaccine Industry Chain Analysis
7.2 Influenza A Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza A Vaccine Production Mode & Process Analysis
7.4 Influenza A Vaccine Sales and Marketing
7.4.1 Influenza A Vaccine Sales Channels
7.4.2 Influenza A Vaccine Distributors
7.5 Influenza A Vaccine Customer Analysis
8 Influenza A Vaccine Market Dynamics
8.1 Influenza A Vaccine Industry Trends
8.2 Influenza A Vaccine Market Drivers
8.3 Influenza A Vaccine Market Challenges
8.4 Influenza A Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
MedImmune
Abbott
Merck
SINOVAC BIOTECH
Changsheng Bio-Technology
Beijing Tiantan Bio-Products
Mitsubishi Tanabe Pharma
GSK
Sanofi
Novartis
Hualan Biological Engineering
List of Tables
 Table 1. Global Influenza A Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Influenza A Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Influenza A Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Influenza A Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Influenza A Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Influenza A Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Influenza A Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Influenza A Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Influenza A Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Influenza A Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Influenza A Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Influenza A Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Influenza A Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Influenza A Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Influenza A Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Influenza A Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Influenza A Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Influenza A Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Influenza A Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Influenza A Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Influenza A Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Influenza A Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Influenza A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Influenza A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Influenza A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Influenza A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Influenza A Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Influenza A Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Influenza A Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Influenza A Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Influenza A Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Influenza A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Influenza A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Influenza A Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Influenza A Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Influenza A Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Influenza A Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Influenza A Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Influenza A Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Influenza A Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Influenza A Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Influenza A Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Influenza A Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Influenza A Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Influenza A Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Influenza A Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Influenza A Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Influenza A Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Influenza A Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Influenza A Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Influenza A Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Influenza A Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Influenza A Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Influenza A Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Influenza A Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Influenza A Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Influenza A Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Influenza A Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Influenza A Vaccine Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Influenza A Vaccine Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Influenza A Vaccine Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Medimmune Company Information
 Table 86. Medimmune Description and Business Overview
 Table 87. Medimmune Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Medimmune Influenza A Vaccine Product
 Table 89. Medimmune Recent Developments/Updates
 Table 90. Abbott Company Information
 Table 91. Abbott Description and Business Overview
 Table 92. Abbott Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Influenza A Vaccine Product
 Table 94. Abbott Recent Developments/Updates
 Table 95. Mitsubishi Tanabe Pharma Company Information
 Table 96. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 97. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Mitsubishi Tanabe Pharma Influenza A Vaccine Product
 Table 99. Mitsubishi Tanabe Pharma Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck Influenza A Vaccine Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Sinovac Biotech Company Information
 Table 106. Sinovac Biotech Description and Business Overview
 Table 107. Sinovac Biotech Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sinovac Biotech Influenza A Vaccine Product
 Table 109. Sinovac Biotech Recent Developments/Updates
 Table 110. Hualan Biological Engineering Company Information
 Table 111. Hualan Biological Engineering Description and Business Overview
 Table 112. Hualan Biological Engineering Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hualan Biological Engineering Influenza A Vaccine Product
 Table 114. Hualan Biological Engineering Recent Developments/Updates
 Table 115. Changsheng Bio-Technology Company Information
 Table 116. Changsheng Bio-Technology Description and Business Overview
 Table 117. Changsheng Bio-Technology Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Changsheng Bio-Technology Influenza A Vaccine Product
 Table 119. Changsheng Bio-Technology Recent Developments/Updates
 Table 120. Beijing Tiantan Bio-Products Company Information
 Table 121. Beijing Tiantan Bio-Products Description and Business Overview
 Table 122. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Beijing Tiantan Bio-Products Influenza A Vaccine Product
 Table 124. Beijing Tiantan Bio-Products Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Influenza A Vaccine Distributors List
 Table 128. Influenza A Vaccine Customers List
 Table 129. Influenza A Vaccine Market Trends
 Table 130. Influenza A Vaccine Market Drivers
 Table 131. Influenza A Vaccine Market Challenges
 Table 132. Influenza A Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Influenza A Vaccine
 Figure 2. Global Influenza A Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Influenza A Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Intramuscular Vaccine Product Picture
 Figure 5. Nasal Spray Vaccine Product Picture
 Figure 6. Global Influenza A Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Influenza A Vaccine Market Share by Application: 2024 & 2031
 Figure 8. 3-18 Years Old
 Figure 9. Above 18 Years Old
 Figure 10. Global Influenza A Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Influenza A Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Influenza A Vaccine Sales (2020-2031) & (K Units)
 Figure 13. Global Influenza A Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Influenza A Vaccine Report Years Considered
 Figure 15. Influenza A Vaccine Sales Share by Manufacturers in 2024
 Figure 16. Global Influenza A Vaccine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Influenza A Vaccine Players: Market Share by Revenue in Influenza A Vaccine in 2024
 Figure 18. Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Influenza A Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Influenza A Vaccine Sales Market Share by Country (2020-2031)
 Figure 21. North America Influenza A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Influenza A Vaccine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Influenza A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Influenza A Vaccine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Influenza A Vaccine Revenue Market Share by Region (2020-2031)
 Figure 33. China Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Influenza A Vaccine Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Influenza A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Influenza A Vaccine Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Influenza A Vaccine Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Influenza A Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Influenza A Vaccine by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Influenza A Vaccine by Type (2020-2031)
 Figure 52. Global Influenza A Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Influenza A Vaccine by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Influenza A Vaccine by Application (2020-2031)
 Figure 55. Global Influenza A Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 56. Influenza A Vaccine Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Drugs and Vaccines Market Research Report 2025
Global Trivalent Flu Vaccine Market Insights Forecast to 2030
Global Quadrivalent Flu Vaccine Market Insights Forecast to 2030
Inactivated Influenza Vaccine Market
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Digital Data Logger Market Insights Forecast to 2030
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Contract Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Trivalent Inactivated Influenza Vaccine Market Research Report 2025
Global Attenuated Vaccine Market Research Report 2025
Global Vaccine Cooler Market Research Report 2025
Global Viral Vaccines Market Research Report 2025
Pediatric Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Glass Vials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccine Administration Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Influenza Antiviral Drugs Market
Refrigerators and Freezers for Vaccine Storage Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions